RecruitingNot ApplicableNCT07175571

SISTER: Sibling Oocyte Insemination With Frozen Sperm From Third Party Donors: Evaluation of Reproductive Techniques

Prospective Randomized Sibling-Oocyte Trial Comparing Fertilization and Embryo Development Outcomes Between Intracytoplasmic Sperm Injection (ICSI) and Conventional IVF Using Frozen Donor Sperm


Sponsor

Shady Grove Fertility Reproductive Science Center

Enrollment

95 participants

Start Date

Sep 15, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to learn whether two different methods of helping eggs and sperm join-intracytoplasmic sperm injection (ICSI) and conventional in vitro fertilization (IVF)-lead to better embryo development when using frozen donor sperm in people who do not have male fertility problems. The main questions it aims to answer are: Does one method create more usable embryos (blastocysts) than the other? Is there a difference in how often fertilization does not happen at all? Do either of the methods lead to better embryo quality or early pregnancy? Participants will: Have their eggs divided into two groups. One group will be fertilized using ICSI (where a sperm is injected directly into an egg), and the other using conventional IVF (where eggs are mixed with sperm in a dish). The fertilization method for each egg will be randomly assigned, with a random process also used to determine the assignment of any extra egg when an odd number is collected. Continue regular fertility treatment while the study team compares the results of each fertilization method. This study includes people with non-male factor infertility and uses frozen donor sperm. It hopes to learn whether ICSI, which is often used even when it may not be needed, truly helps improve outcomes compared to conventional IVF in these cases.


Eligibility

Sex: FEMALE

Inclusion Criteria5

  • Female patients undergoing IVF with frozen donor sperm at Shady Grove Fertility Center
  • Normal ovarian reserve (AMH \> 1 ng/mL, AFC \> 10)
  • Absence of male factor infertility
  • Post-wash parameters: \>50% motility, \>5mil concentration
  • \> 4 oocytes retrieved at time of transvaginal oocyte retrieval

Exclusion Criteria2

  • Donor Sperm with significant male factor infertility (e.g., abnormal sperm concentration, motility, or morphology)
  • Any medical condition contraindicating ART

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREIntracytoplasmic Sperm Injection (ICSI)

Mature oocytes are injected with a single frozen-thawed donor sperm cell using micromanipulation under a microscope. This fertilization method is performed shortly after oocyte retrieval. Sperm used are pre-screened and standardized for post-thaw motility and morphology. ICSI is conducted in accordance with standard embryology lab protocols. The oocyte allocation to ICSI is randomized within each participant's cycle.

PROCEDUREConventional Insemination (IVF)

Oocytes are inseminated by co-incubation with frozen-thawed donor sperm in a culture dish for 16-18 hours. Sperm are washed and prepared according to lab protocol to ensure motility and concentration suitability. This method does not involve direct sperm injection. Oocytes are randomly assigned to this method within each participant's retrieved cohort.


Locations(1)

Shady Grove Fertility Rockville

Rockville, Maryland, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07175571


Related Trials